MEDS News

Gainers Disc Medicine (NASDAQ:IRON) stock moved upwards by 50.4% to $85.51 during Monday's pre-market session. The company's market cap stands at $2.1 billion. DataMEDS AI (NASDAQ:MEDS) shares moved upwards byread more...

Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.read more...

From record-setting biomaterials production to an acquisition designed to strengthen a Nasdaq-listed company's balance sheet, several small-cap companies are pursuing strategic moves that could reshape their commercial prospects. Kraig Biocraft Laboratories (OTCQB:KBLB) is expanding its spider silk production ambitions, J-Star Holding (NASDAQ:YMAT) is targeting automated U.S. drone manufacturing, Euro Tech Holdings (NASDAQ:CLWT) is opening a Norwegian market-entry platform, and Gix Internet (NASDAQ:GIXI) is extending AI-powered hospital robotics into additional clinical logistics. DataMeds AI (NASDAQ:MEDS) says its Helomics subsidiary has secured a Humana Medicaid coverage determination for its ChemoFx assay in certain gynecologic cancer cases, while Dot Ai (NASDAQ:DAIC) has completed an approximately $65 million all-stock acquisition of electric vehicle carsharing company, Envoy Technologies.

Stocks are charging into October with Nexalin Technology (NASDAQ:NXL), NeOnc Technologies Holdings (NASDAQ:NTHI), Airship AI Holdings (NASDAQ:AISP), DataMeds AI (NASDAQ:MEDS), Veea (NASDAQ:VEEA), Inseego (NASDAQ:INSG), and Enerflex (NYSE:EFXT) tied to developments that give investors fresh reasons to put these names on the radar.

Small-cap stocks are kicking off October with a mix of milestones, putting Nexalin Technology (NASDAQ:NXL), Kraig Biocraft Laboratories (OTCQB:KBLB), Veea (NASDAQ:VEEA), DataMeds AI (NASDAQ:MEDS), Generation Income Properties (NASDAQ:GIPR),  and American Battery Technology Company (NASDAQ:ABAT) firmly on the radar.

DataMeds AI (NASDAQ:MEDS) is entering October with a fresh revenue milestone that puts the company's rapidly expanding healthcare platform squarely in focus. Corexa Pharmacy, a division of wholly owned Corexa Health, generated preliminary, unaudited September 2026 revenue of more than $1 million, representing an increase of more than 66% from July 2026, according to the company. The update comes only months after DataMeds changed its corporate name from Wellgistics Health and its Nasdaq ticker from WGRX to MEDS, while repositioning the business around pharmacy infrastructure, health technology, artificial intelligence and pharmaceutical-adjacent services.

Kodiak Sciences (NASDAQ:KOD), NeOnc Technologies Holdings (NASDAQ:NTHI), KNOREX (NYSEAMERICAN:KNRX), DataMeds AI (NASDAQ:MEDS), Accuray (NASDAQ:ARAY) and AMC Entertainment (NYSE:AMC) are each approaching important milestones that could reshape how investors view their pipelines, platforms and near-term prospects.

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX) stock roseread more...

Major U.S. indices ended Wednesday in the red as the Federal Reserve raised interest rates by 0.25%, marking the first increase since 2023. The Dow Jones Industrial Average fell 1.2% to 51,461.90, while the S&Pread more...